Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 111.64B | 110.39B | 105.20B | 106.17B | 95.71B | 65.83B |
Gross Profit | 62.28B | 62.14B | 57.27B | 54.17B | 45.19B | 28.36B |
EBITDA | 44.76B | 46.71B | 36.80B | 39.10B | 32.48B | 17.59B |
Net Income | 27.89B | 27.74B | 21.38B | 20.68B | 16.67B | 5.33B |
Balance Sheet | ||||||
Total Assets | 161.04B | 151.82B | 138.02B | 126.38B | 127.41B | 95.20B |
Cash, Cash Equivalents and Short-Term Investments | 40.12B | 34.98B | 37.41B | 29.29B | 29.36B | 20.53B |
Total Debt | 21.12B | 21.08B | 21.73B | 19.71B | 19.43B | 15.48B |
Total Liabilities | 64.25B | 55.90B | 53.06B | 52.61B | 63.27B | 41.90B |
Stockholders Equity | 96.79B | 95.92B | 84.95B | 72.89B | 63.73B | 53.30B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 26.36B | 16.52B | 9.55B | 20.55B | 10.45B |
Operating Cash Flow | 0.00 | 40.43B | 27.46B | 21.34B | 25.80B | 13.19B |
Investing Cash Flow | 0.00 | -22.32B | -10.87B | -9.45B | -12.43B | -2.47B |
Financing Cash Flow | 0.00 | -21.29B | -10.34B | -12.54B | -5.78B | -4.26B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | $330.63B | 17.91 | 13.42% | 5.59% | 14.76% | 36.77% | |
79 Outperform | ¥366.51B | 13.06 | 3.02% | 4.94% | 31.90% | ||
79 Outperform | $310.39B | 8.14 | 9.28% | 4.00% | 2.73% | ― | |
69 Neutral | ¥228.59B | 14.33 | 7.64% | 2.71% | 9.13% | 8.49% | |
62 Neutral | $275.40B | 24.02 | -0.56% | 4.10% | 3.02% | 48.28% | |
60 Neutral | ¥344.60B | 826.21 | 0.43% | 1.34% | -0.23% | -91.56% | |
58 Neutral | ¥323.14B | 137.82 | 3.50% | 5.82% | -71.97% |
Dexerials Corporation announced the disposition of 18,666 shares of its treasury stock as part of a restricted stock compensation plan aimed at incentivizing executive management candidates. This plan is designed to enhance corporate value and align the interests of employees with those of shareholders, with a transfer restriction period set from July 2025 to June 2028.
The most recent analyst rating on (JP:4980) stock is a Hold with a Yen2100.00 price target. To see the full list of analyst forecasts on Dexerials Corp. stock, see the JP:4980 Stock Forecast page.
Dexerials Corporation has announced a change in its leadership, appointing Katsushi Kitajo as the new Representative Director, succeeding Toshiya Satake. This change aims to strengthen corporate governance and accelerate the execution of the company’s Mid-Term Management Plan, thereby enhancing corporate value over the medium to long term.
The most recent analyst rating on (JP:4980) stock is a Hold with a Yen2100.00 price target. To see the full list of analyst forecasts on Dexerials Corp. stock, see the JP:4980 Stock Forecast page.
Dexerials Corporation announced an additional cash contribution of ¥1,000 million to its Board Benefit Trust-Restricted Stock system to acquire up to 700,000 common shares. This move aims to sustain the company’s stock compensation plan for directors, potentially strengthening its governance and aligning management interests with shareholders.
Dexerials Corporation reported a strong financial performance for the fiscal year ending March 31, 2025, with net sales increasing by 4.9% to 110,390 million yen and a significant rise in operating profit by 24.6%. The company also conducted a 3-for-1 stock split, impacting earnings per share calculations. Despite the positive results, the forecast for the next fiscal year indicates a decline in net sales and profits, suggesting potential challenges ahead.